/SiteAssets/Images/FMOLHSBlankBanner.png

Health Information

Retinal vein occlusion
Bookmarks

Retinal vein occlusion

Print-Friendly  

Central retinal vein occlusion; Branch retinal vein occlusion; CRVO; BRVO

Retinal vein occlusion is a blockage of the small veins that carry blood away from the retina. The retina is the layer of tissue at the back of the inner eye that converts light images to nerve signals and sends them to the brain.

I Would Like to Learn About:

  • Causes

    Retinal vein occlusion is most often caused by hardening of the arteries (atherosclerosis) and the formation of a blood clot.

    Blockage of smaller veins (branch veins or BRVO) in the retina often occurs in places where retinal arteries that have been thickened or hardened by atherosclerosis cross over and place pressure on a retinal vein.

    Risk factors for retinal vein occlusion include:

    • Atherosclerosis
    • Diabetes
    • High blood pressure (hypertension)
    • Other eye conditions, such as glaucoma, macular edema, or vitreous hemorrhage

    The risk of these disorders increases with age, therefore retinal vein occlusion most often affects older people.

    Blockage of retinal veins may cause other eye problems, including:

    • Glaucoma (high pressure in the eye), caused by new, abnormal blood vessels growing in the front part of the eye
    • Macular edema, caused by the leakage of fluid in the retina
  • Symptoms


    • Sudden blurring or vision loss in all or part of one eye
  • Exams and Tests

    Tests to evaluate for vein occlusion include:

    • Exam of the retina after dilating the pupil
    • Fluorescein angiography
    • Intraocular pressure
    • Pupil reflex response
    • Refraction
    • Retinal photography
    • Slit lamp examination
    • Testing of side vision (visual field examination)
    • Visual acuity

    Other tests may include:

    • Blood tests for diabetes, high cholesterol, and triglyceride levels
    • Blood tests to look for a clotting or blood thickening (hyperviscosity) problem (in patients under age 40)

    The health care provider will closely monitor any blockage for several months. It may take 3 or more months for harmful effects such as glaucoma to develop after the occlusion.

  • Treatment

    Many people will regain vision, even without treatment. However, vision rarely returns to normal. There is no way to reverse or open the blockage.

    You may need treatment to prevent another blockage from forming in the same or the other eye.

    It's important to manage diabetes, high blood pressure, and high cholesterol levels. Some people may need to take aspirin or other blood thinners.

    Treatment for the complications of retinal vein occlusion may include:

    • Focal laser treatment, if macular edema is present
    • Injections of anti-vascular endothelial growth factor (anti-VEGF) drugs into the eye. These drugs may block the growth of new blood vessels that can cause glaucoma. This treatment is still being studied.
    • Laser treatment to prevent the growth of new, abnormal blood vessels that leads to glaucoma
  • Outlook (Prognosis)

    The outcome varies. Patients with retinal vein occlusion often regain useful vision.

    It is important to properly manage conditions such as macular edema and glaucoma. However, having either of these complications is more likely to lead to a poor outcome.

  • Possible Complications


    • Glaucoma
    • Partial or complete vision loss in the affected eye
  • When to Contact a Medical Professional

    Call your health care provider if you have sudden blurring or vision loss.

  • Prevention

    Retinal vein occlusion is a sign of a general blood vessel (vascular) disease. Measures used to prevent other blood vessel diseases may decrease the risk of retinal vein occlusion.

    These measures include:

    • Eating a low-fat diet
    • Getting regular exercise
    • Maintaining an ideal weight
    • Not smoking

    Aspirin or other blood thinners may help prevent blockages in the other eye.

    Controlling diabetes may help prevent retinal vein occlusion.

Related Information

     

References

Sanborn GE, Magargal LE. Venous occlusive disease of the retina. In: Tasman W, Jaeger EA, eds. Duane's Clinical Ophthalmology. 2013 ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2013:vol 3, chap 15.

Reiss GR, Sipperley JO, Gaitan JR. Glaucoma Associated with Retinal Disorders and Retinal Surgery. In: Tasman W, Jaeger EA, eds. Duane's Clinical Ophthalmology. 2013 ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2013:vol 3; chap 54E.

Wu L, Arevalo JF, Roca JA, Maia M, Berrocal MH, Rodriguez FJ, et al. Pan-American Collaborative Retina Study Group (PACORES). Comparison of two doses of intravitreal bevacizumab (Avastin) for treatment of macular edema secondary to branch retinal vein occlusion: results from the Pan-American Collaborative Retina Study Group at 6 months of follow-up. Retina. 2008;28:212-219.

Kreutzer TC, Alge CS, Wolf AH, Kook D, Burger J, Strauss R, et al. Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion. Br J Ophthalmol. 2008;92:351-355.

Crouch ER, Crouch ER, Grant TR. Ophthalmology. In: Rakel RE, ed. Textbook of Family Medicine. 8th ed. Philadelphia, PA: Saunders Elsevier; 2011:chap 41.

BACK TO TOP 

Review Date: 5/8/2014  

Reviewed By: Franklin W. Lusby, MD, Ophthalmologist, Lusby Vision Institute, La Jolla, CA. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

adam.com

 
A.D.A.M. content is best viewed in IE9 or above, Fire Fox and Google Chrome browser.